| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.14 | 0.5 |